MAP3K13 Antikörper (C-Term, Ser869)
Kurzübersicht für MAP3K13 Antikörper (C-Term, Ser869) (ABIN2306944)
Target
Alle MAP3K13 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term, Ser869
-
Kreuzreaktivität
- Human
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
-
Produktmerkmale
- MAP3K13, CT (S869) (MAP3K13, LZK, Mitogen-activated protein kinase kinase kinase 13, Leucine zipper-bearing kinase, Mixed lineage kinase)
-
Aufreinigung
- Purified by Protein A affinity chromatography.
-
Immunogen
- MAP3K13 (LZK) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide selected from the C-terminal region of human LZK.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- MAP3K13 (Mitogen-Activated Protein Kinase Kinase Kinase 13 (MAP3K13))
-
Andere Bezeichnung
- MAP3K13
-
UniProt
- O43283
-
Pathways
- Signaling Events mediated by VEGFR1 and VEGFR2
Target
-